LUMAXTECHNSELumax Auto Technologies Limited· Auto AncillariesHighNeutral
Announced Thu, 29 May · 18:02 IST

Lumax Auto Technologies Limited has informed the Exchange about Convening and holding the 44th Annual General Meeting ("AGM") of the Company on Monday.August 25. 2025 for the Financial Year ended March 31. 2025. through Video Conferencing/other Audio-visual means

Revenue Growth 20pctPat Growth 25pctPat NegativeRelated Party TransactionsResults View source PDF

LUMAXTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lumax Auto Technologies reported FY25 consolidated revenue of Rs. 3,63,667 lakhs, up about 29% from Rs. 2,82,174 lakhs in FY24, partly helped by the Greenfuel Energy acquisition from November 2024. Consolidated profit after tax rose about 37% to Rs. 22,916 lakhs versus Rs. 16,696 lakhs last year. On a standalone basis, revenue grew around 10.5% to Rs. 1,47,542 lakhs, but standalone profit fell roughly 20% to Rs. 7,394 lakhs versus Rs. 9,266 lakhs. The Board recommended a final dividend of Rs. 5.50 per share (275% on face value of Rs. 2), subject to shareholder approval. Statutory auditor Price Waterhouse Chartered Accountants LLP gave an unmodified opinion on both standalone and consolidated results. Other key decisions include a CFO change (Mr. Ashish Dubey retires June 30, 2025, replaced by Mr. Ankit Thakral from July 1, 2025), a small solar energy investment, purchase of land in Gujarat, incorporation of two wholly owned subsidiaries, and shareholder approval sought for material related party transactions with Lumax Industries for FY26. The 44th AGM is set for August 25, 2025, with record date of August 7, 2025.

Likely market impact

Positive signals from strong consolidated growth and a healthy dividend, but standalone profit decline and CFO transition may draw investor attention. The AGM and related-party transaction approval are routine governance items with no immediate price impact expected.